Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaswiss Česká republika s.r.o. - tadalafil - filmsko obložena tableta - tadalafil 20 mg / 1 tableta - tadalafil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaswiss Česká republika s.r.o. - tadalafil - filmsko obložena tableta - tadalafil 10 mg / 1 tableta - tadalafil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaswiss Česká republika s.r.o. - tadalafil - filmsko obložena tableta - tadalafil 5 mg / 1 tableta - tadalafil

Evropska unija - slovenščina - EMA (European Medicines Agency)

eli lilly nederland b.v. - tadalafil - erektilna disfunkcija - urološki - zdravljenje erektilne disfunkcije. za učinkovitost tadalafila je potrebna spolna stimulacija. cialis ni označeno za uporabo žensk.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belupo, lijekovi i kozmetika, d.d. - filmsko obložena tableta - tadalafil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belupo, lijekovi i kozmetika, d.d. - filmsko obložena tableta - tadalafil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan s.a.s. - tadalafil - filmsko obložena tableta - tadalafil 20 mg / 1 tableta - tadalafil

Evropska unija - slovenščina - EMA (European Medicines Agency)

roche registration ltd. - nelfinavir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - zdravilo viracept je indicirano pri protiretrovirusnem kombiniranem zdravljenju odraslih, mladostnikov in otrok, starih treh let in starejših, pri ljudeh, pri katerih je virus hiv-1. v protease-serotonina (pi)-izkušeni bolniki, izbira nelfinavir, ki mora temeljiti na posameznih virusnih odpornost testiranje in zdravljenje zgodovina.

Evropska unija - slovenščina - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hipertenzija, pljučnica - antihipertenzivi, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Evropska unija - slovenščina - EMA (European Medicines Agency)

bayer ag - riociguat - hipertenzija, pljučnica - antihipertenzivi za pljučno arterijsko hipertenzijo - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. učinkovitosti je bil prikazan v pah prebivalstva, vključno z aetiologies z idiopatsko ali dedne pah ali pah, povezanih z vezivnega tkiva bolezni. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.